Literature DB >> 22227675

Autoimmunity's next top models.

Hartmut Wekerle1, Alexander Flügel, Lars Fugger, Georg Schett, David Serreze.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22227675     DOI： 10.1038/nm.2635

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  48 in total

Review 1.  Genomics and the multifactorial nature of human autoimmune disease.

Authors:  Judy H Cho; Peter K Gregersen
Journal:  N Engl J Med       Date:  2011-10-27       Impact factor: 91.245

Review 2.  Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.

Authors:  Lawrence Steinman; Scott S Zamvil
Journal:  Trends Immunol       Date:  2005-09-08       Impact factor: 16.687

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

5.  Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

Authors:  F M Brennan; D Chantry; A Jackson; R Maini; M Feldmann
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

6.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

Review 7.  Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.

Authors:  Heinz Wiendl; Reinhard Hohlfeld
Journal:  Neurology       Date:  2009-03-17       Impact factor: 9.910

8.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  A prescription for human immunology.

Authors:  Mark M Davis
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745
View more
  21 in total

Review 1.  How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy.

Authors:  Georg Schett; Dirk Elewaut; Iain B McInnes; Jean-Michel Dayer; Markus F Neurath
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

2.  Of men, not mice.

Authors: 
Journal:  Nat Med       Date:  2013-04       Impact factor: 53.440

Review 3.  Safe clinical use of carbon nanotubes as innovative biomaterials.

Authors:  Naoto Saito; Hisao Haniu; Yuki Usui; Kaoru Aoki; Kazuo Hara; Seiji Takanashi; Masayuki Shimizu; Nobuyo Narita; Masanori Okamoto; Shinsuke Kobayashi; Hiroki Nomura; Hiroyuki Kato; Naoyuki Nishimura; Seiichi Taruta; Morinobu Endo
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

4.  In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis.

Authors:  Klara Kirschbaum; Jana K Sonner; Matthias W Zeller; Katrin Deumelandt; Julia Bode; Rakesh Sharma; Thomas Krüwel; Manuel Fischer; Angelika Hoffmann; Milene Costa da Silva; Martina U Muckenthaler; Wolfgang Wick; Björn Tews; John W Chen; Sabine Heiland; Martin Bendszus; Michael Platten; Michael O Breckwoldt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

5.  [Multiple sclerosis and microbiota. From genome to metagenome?].

Authors:  R Hohlfeld; H Wekerle
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 6.  Mouse Models of Primary Sjogren's Syndrome.

Authors:  Young-Seok Park; Adrienne E Gauna; Seunghee Cha
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 7.  Impacts of microbiome metabolites on immune regulation and autoimmunity.

Authors:  Stefanie Haase; Aiden Haghikia; Nicola Wilck; Dominik N Müller; Ralf A Linker
Journal:  Immunology       Date:  2018-04-30       Impact factor: 7.397

8.  Subclinical CNS inflammation as response to a myelin antigen in humanized mice.

Authors:  Morad Zayoud; Khalifa El Malki; Katrin Frauenknecht; Bettina Trinschek; Luise Kloos; Khalad Karram; Florian Wanke; Julia Georgescu; Udo F Hartwig; Clemens Sommer; Helmut Jonuleit; Ari Waisman; Florian C Kurschus
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-03       Impact factor: 4.147

Review 9.  Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?

Authors:  Y Simoni; J Diana; L Ghazarian; L Beaudoin; A Lehuen
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

Review 10.  Immune reconstitution therapies: concepts for durable remission in multiple sclerosis.

Authors:  Jan D Lünemann; Heinz Wiendl; Tobias Ruck; Paolo A Muraro; Amit Bar-Or
Journal:  Nat Rev Neurol       Date:  2019-10-24       Impact factor: 42.937
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.